Fig. 2: Prevalence ratio (PR) and 95% confidence intervals (CI) of COVID-19 vaccine uptake, according to specialist diagnosis of mental illness and prescribed use of psychiatric medication, in the Swedish register study population. | Nature Communications

Fig. 2: Prevalence ratio (PR) and 95% confidence intervals (CI) of COVID-19 vaccine uptake, according to specialist diagnosis of mental illness and prescribed use of psychiatric medication, in the Swedish register study population.

From: Mental illness and COVID-19 vaccination: a multinational investigation of observational & register-based data

Fig. 2: Prevalence ratio (PR) and 95% confidence intervals (CI) of COVID-19 vaccine uptake, according to specialist diagnosis of mental illness and prescribed use of psychiatric medication, in the Swedish register study population.

A first dose of a COVID-19 vaccine by 30th September 2021 and (B) second dose of a COVID-19 vaccine by 30th November 2021. Data are presented as PR with 95% CIs (horizontal lines), rounded to 2 decimal places. All estimates are adjusted for age, sex, region of residence, highest educational attainment, cohabitation status, income, severe COVID-19 infection and the Charlson Comorbidity Index (CCI). Substance use disorder excludes alcohol and tobacco use disorders. N = (A) 7,883,298; (B) 6,728,266.

Back to article page